The tariff classification of Bromocriptine Mesylate Tablets (2.5 mg) and Capsules (5 mg), Bicalutamide Tablets (50 mg), and Dipyridamole Tablets (25mg, 50 mg, 75 mg) from India
Reasoning
The tariff classification of Bromocriptine Mesylate Tablets (2.5 mg) and Capsules (5 mg), Bicalutamide Tablets (50 mg), and Dipyridamole Tablets (25mg, 50 mg, 75 mg) from India
Cite this ruling
CBP Ruling N022256 (3004400040): The tariff classification of Bromocriptine Mesylate Tablets (2.5 mg) and Capsules (5 mg), Bicalutamide Tablets (50 mg), and Dipyridamole Tablets (25mg, 50 mg, 75 mg) from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300440
The tariff classification of AVP-923 Capsules from Canada
Reminyl™ Tablets and Galantamine Hydrobromide
The tariff classification of Dehydrated Alcohol Injection, USP; Caffeine and Sodium Benzoate Injection, USP; Methylene Blue Injection, USP 1%; Sodium Thiosulfate Injection, USP; and Physostigmine Salicylate Injection, from Ireland
The tariff classification of Dehydrated Alcohol Injection, USP; Caffeine and Sodium Benzoate Injection, USP; Methylene Blue Injection, USP 1%; Sodium Thiosulfate Injection, USP; and Physostigmine Salicylate Injection, from Ireland
Classification of "Prostep", a nicotine Transdermal DeliverySystem from Ireland; NY 868637 Revoked